Simon Allen - Feb 1, 2022 Form 3 Insider Report for Anebulo Pharmaceuticals, Inc. (ANEB)

Role
Chief Executive Officer
Signature
/s/ James R. Merchant, as Attorney-in-Fact
Stock symbol
ANEB
Transactions as of
Feb 1, 2022
Transactions value $
$0
Form type
3
Date filed
2/7/2022, 03:05 PM
Next filing
Feb 7, 2022

No securities are beneficially owned.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney